Between 2024 and 2028, the diuretic medicine sales in Canada are forecasted to experience continuous growth. Starting at 397.7 million Canadian Dollars in 2024, the market is projected to grow to 461.0 million Canadian Dollars by 2028. The year-on-year percentage increase shows a steady upward trend, reflecting consistent market demand and potentially increased incidence of conditions requiring diuretics.
The compound annual growth rate (CAGR) from 2024 to 2028 highlights the robust growth anticipated over this five-year period.
Future trends to watch for include potential advancements in diuretic formulations, regulatory adjustments in healthcare policies, and demographic changes such as an aging population, which may further boost demand for diuretic medications.
